Strata Critical Medical, Inc. (SRTA) — Strategic Asset Allocation Index
Strata Critical Medical, Inc. (SRTA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $- plus long-term investments of $390.00K) total $390.00K, measured against net assets of $274.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Strata Critical Medical, Inc. net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strata Critical Medical, Inc. Strategic Asset Allocation Index (2021–2022)
This chart shows how Strata Critical Medical, Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $390.00K against net assets of $274.49 Million USD. For live market cap and overall valuation, see SRTA market cap.
Annual Strategic Asset Allocation Index for Strata Critical Medical, Inc. (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Strata Critical Medical, Inc. from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Strata Critical Medical, Inc. book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $390.00K | $- | $390.00K | $274.49 Million | ▲ +0.1 pp |
| 2021 | 0.1% | $200.00K | $- | $200.00K | $291.37 Million | — |